{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.1","upperLimit":"11.1","value":"4.3"},{"comment":"No patients experienced outcome, so confidence interval is not applicable\"?","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"0"},{"groupId":"OG002","lowerLimit":"0.4","upperLimit":"37.6","value":"10.0"},{"groupId":"OG003","lowerLimit":"0.5","upperLimit":"37.4","value":"10.0"},{"groupId":"OG004","lowerLimit":"0.2","upperLimit":"11.4","value":"2.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"40"}],"units":"Participants"}],"description":"Kalbfleisch and Prentice estimate of the percentage of experiencing any severity chronic GVHD one year after the date of transplant. (Events=chronic GVHD, competing events=death) Groups with insufficient events for confidence interval estimation have confidence intervals written as \"NA to NA.\"","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients who met eligibility criteria and received transplant.","id":"OG000","title":"All Transplant Participants"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^5 cells/kg","id":"OG001","title":"Dose 1"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^6 cells/kg","id":"OG002","title":"Dose 2"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^7 cells/kg","id":"OG003","title":"Dose 3"},{"description":"Patients who met eligibility criteria, received transplant, and were assigned the MED dose of 1x10\\^7 cells/kg","id":"OG004","title":"Phase 2"}],"paramType":"NUMBER","populationDescription":"Patients who met eligibility criteria and received transplant.","reportingStatus":"POSTED","timeFrame":"One year after receiving transplant","title":"The Cumulative Incidence of Any Severity Chronic Graft-Versus-Host Disease (GVHD)","type":"SECONDARY","unitOfMeasure":"percentage of participants"}